Early peanut introduction; asthma risk in teens on contraceptives

August 04, 2023 1 min read ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . " data-action"subscribe"> Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Guidelines from the National Institute of Allergy and Infectious Diseases recommends introducing peanut into the diets of high-risk infants between age 4 and 6 months. Yet, just 13.3% of parents and caregivers were aware of these guidelines, according to a study published in Pediatrics. It was the top story in allergy/asthma last week. Just 13.3% of parents and caregivers were aware of guidelines on early peanut introduction, according to a study published in Pediatrics. Image source: Adobe Stock The second top story was about girls’ risk for developing asthma after beginning hormonal contraceptive treatment before age 18 years. Researchers reported that the cumulative risk for new asthma was 2.7% after 3 years of beginning hormonal contraceptives. Read these and more top stories in allergy/asthma below: 13.3% of caregivers aware of guidelines for early peanut introduction The percentage of parents and other caregivers who know they should introduce peanuts into their infants’ diets to prevent allergy is improving, but disparities between populations exist, according to a study published in Pediatrics. Read more. Asthma development associated with hormonal contraceptive use during adolescence Girls who began hormonal contraceptive treatment before age 18 years experienced greater risk for developing asthma than girls who did not, according to a study published in the Journal of Allergy and Clinical Immunology: In Practice. Read more. VIDEO: Manage patient relationships by following the Golden Rule Providers need to manage patient relationships to prevent poor outcomes for everyone, according to an Association of PAs in Allergy, Asthma and Immunology Annual Allergy, Asthma & Immunology CME Conference presentation. Watch video. Biologics comparably effective in controlling eosinophilic severe asthma symptoms Nucala (mepolizumab, GSK), Cinqair (reslizumab, Teva Pharmaceutical Industries Ltd.) and Dupixent (dupilumab; Sanofi, Regeneron) were equally effective in controlling symptoms among patients with eosinophilic severe asthma, according to a study published in Annals of Allergy, Asthma & Immunology. Read more. Physician assistants, nurse practitioners evolve with asthma, allergy care As asthma and allergy treatment evolves, physicians, physician assistants and nurse practitioners will work together to ensure effective care, according to Andrew Liu, MD, FAAAAI, of Children’s Hospital Colorado. Read more. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . " data-action"subscribe"> Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Sources 1/ https://Google.com/ 2/ https://www.healio.com/news/primary-care/20230802/top-in-allergyasthma-early-peanut-introduction-asthma-risk-in-teens-on-contraceptives The mention sources can contact us to remove/changing this article